Edwards Lifesciences | EW - Spese Di Vendita E Di Amministrazione

Prezzo Delle Azioni
84.15
Cambio Giornaliero
4.43 5.56%
Mensile
1.79%
Annuale
10.67%
Q2 Previsione
82.35




Spese Di Vendita E Di Amministrazione Cambiamento Data
Abbott USD 3.27B 138M 2026-03
Artivion USD 55.75M 4.54M 2025-12
AtriCure USD 78.34M 109K 2025-12
Baxter International USD 761M 53M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Boston Scientific USD 1.83B 93M 2025-12
Cooper Companies USD 373.1M 46.1M 2025-12
Dexcom USD 299.9M 31.5M 2025-12
Edwards Lifesciences USD 522.2M 80.7M 2026-03
Globus Medical USD 318.48M 4.88M 2025-12
ICU Medical USD 155.81M 3.04M 2025-12
Inogen USD 43.77M 510K 2024-06
Insulet USD 331.4M 16.2M 2025-12
Integra LifeSciences USD 156.45M 12.6M 2025-12
Intuitive Surgical USD 613.3M 73.8M 2026-03
J&J USD 6.03B 719M 2026-03
Masimo USD 128M 11.6M 2025-12
Medtronic 2.97B 159M 2025-09
Merit Medical Systems USD 114.83M 7.45M 2025-12
Stryker USD 2.14B 150M 2025-12
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 222.37M 59.4M 2025-12
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12